We take pride in our approach to integrated research, education, and clinical care. It enables us to deliver the most advanced treatments and technologies to patients. We are seeing faster progress in treatment areas and the adoption of new tools for cancer screening and prevention, which are transforming lives in Iowa and beyond.

Bri O’Leary, PhD, in the Joseph Cullen lab on Tuesday, Dec. 17, 2024.

Iowa’s only

NCI-designated Comprehensive Cancer Center
Marion Vanneste, postdoctoral research scholar in the Department of Molecular Physiology and Biophysics on Friday, Dec. 2, 2022.

290 +

Members
Exterior of Holden Comprehensive Cancer Center with new brand campaign display at University of Iowa Health Care’s university campus on Tuesday, July 22, 2025.

200 +

clinical research trials open

Latest Holden News

Ronald J. Weigel, MD, PhD, MBA, and Songhai Chen, MD, PhD

Weigel awarded NIH training grant to support future surgeon-scientists

Friday, August 7, 2026
Holden members Ronald J. Weigel, MD, PhD, MBA, Professor and Chair Emeritus of the Department of Surgery in the Division of Surgical Oncology and Endocrine Surgery, and Songhai Chen, MD, PhD, Professor of Neuroscience and Pharmacology have been awarded a prestigious National Cancer Institute of the National Institutes of Health T32 training grant to establish the University of Iowa Surgical Oncology Research Training Program.
NET SPORE group

NET SPORE

Monday, April 13, 2026
UI Health Care receives Specialized Program of Research Excellence funding for neuroendocrine tumors.
Colin Kenny lab

UI researcher tackles rare eye cancer through novel approaches

Monday, April 6, 2026
Using zebrafish, UI professor Colin Kenny studies uveal melanoma to better understand how it forms and spreads — and how it can be treated. His dedication to research comes from what he calls the “sheer thrill of discovery.”

Support our research and programs

Your gift will help to advance our mission of advancing cancer medical research.